Answers are grounded in this paper and cite their sources.
Instigating effective treatment regimens in a way that improves patient adherence is vital to tackling the global resurgence of tuberculosis About one third of the world's population has latent tuberculosis, caused by Mycobacterium tuberculosis infection.1 From this pool, roughly 9 million cases of active tuberculosis emerge annually, resulting in 2-3 million deaths. Most new cases occur in the most populated nations—India and China—but the highest rates of disease are seen in sub-Saharan Africa, the Indonesian and Philippine archipelagos, Afghanistan, Bolivia, and Peru. In these regions case rates typically exceed 300 cases per 100 000 per year. 1 2 Although the incidence of tuberculosis declined in North America and western Europe throughout most of the latter half of the 20th century, case rates have increased over the past 10 years mainly because of immigration, HIV/AIDS, and the neglect of tuberculosis control programmes. 3 4 One vital factor in curbing the increase of tuberculosis is the instigation of proper treatment that not only encompasses an effective regimen but also ensures compliance with and response to treatment. This review highlights current treatment recommendations for tuberculosis. #### Summary points Many people worldwide have latent or active tuberculosis, and the number of active cases is expected to increase in the future The most common cause of treatment failure and acquired drug resistance is non-adherence; predicting non-adherence is highly problematic Directly observed therapy is the most effective means of combatting non-adherence; intermittent (less than daily) regimens facilitate the therapy Testing the susceptibility of Mycobacterium tuberculosis to drugs is essential for identifying resistance and tailoring treatment Managing multidrug resistant tuberculosis is complex and should, when possible, be done in specialised programmes We performed a Medline search of the past 10 years using the key words “tuberculosis and treatment or drug therapy” to find pertinent literature. We also searched bibliographies …
No takes yet. Share an insight, caveat, or question.
Edward D. Chan (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: